This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsushita, S. Articles by Akiyama, S.-i. Search for Related Content PubMed PubMed Citation Articles by Matsushita, S. Articles by Akiyama, S.-i.

The Effect of a Thymidine Phosphorylase Inhibitor on Angiogenesis and Apoptosis in Tumors¹

Department of Cancer Chemotherapy, Institute for Cancer Research [S. M., T. F., T. S., A. T., K. N., S-i. A.], Department of Dermatology [S. M., T. K.], 1st Department of Pathology [T. N., H. Y.], and Department of Public Health [S. A.], Kagoshima University, Kagoshima 890-8520, and Taiho Pharmaceutical Co. Ltd., Misugidai 1-27 Hanno 357 [K. M., M. F., Y. Y.], Japan

Thymidine phosphorylase (TP) is an enzyme involved in the reversible conversion of thymidine to thymine and is identical to an angiogenic factor, platelet-derived endothelial cell growth factor. TP is expressed at higher levels in a wide variety of solid tumors than in the adjacent nonneoplastic tissues. Patients with TP-positive colon and esophageal tumors have a poorer prognosis than those with TP-negative tumors. We have recently synthesized a new TP inhibitor (TPI), 5-chloro-6-[1-(2-iminopyrrolidinyl) methyl] uracil hydrochloride. We investigated the effect of TPI on angiogenesis in KB cells transfected with platelet-derived endothelial cell growth factor cDNA, KB/TP, and a mock transfectant, KB/CV, using the mouse dorsal air sac assay model. We found that KB/TP cells had a higher angiogenic ability than KB/CV cells and that TPI completely suppressed angiogenesis by KB/TP. Furthermore, at a dose of 50 mg/kg/day, TPI considerably decreased the growth rate of KB/TP cells xenografted into nude mice. Microvessel density in KB/TP tumors was higher than that in KB/CV tumors, and TPI did not significantly change the density in either of the tumors. The apoptotic index in KB/TP tumors was significantly lower than that in KB/CV tumors, and TPI significantly increased the apoptotic index in KB/TP tumors but not in KB/CV tumors. These findings, taken together with previous reports, suggest that the expression of TP plays an important role in tumor growth and that TPI suppresses tumor growth by increasing the proportion of apoptotic cells and probably inhibiting angiogenesis.

This article has been cited by other articles:

				X. Wang, G. H. Hockerman, H. W. Green III, C. F. Babbs, S. I. Mohammad, D. Gerrard, M. A. Latour, B. London, K. M. Hannon, and A. L. Pond Merg1a K+ channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway FASEB J, July 1, 2006; 20(9): 1531 - 1533. [Abstract] [Full Text] [PDF]

				S. Liekens, A.-I. Hernandez, D. Ribatti, E. De Clercq, M.-J. Camarasa, M.-J. Perez-Perez, and J. Balzarini The Nucleoside Derivative 5'-O-Trityl-inosine (KIN59) Suppresses Thymidine Phosphorylase-triggered Angiogenesis via a Noncompetitive Mechanism of Action J. Biol. Chem., July 9, 2004; 279(28): 29598 - 29605. [Abstract] [Full Text] [PDF]

				Y. Nakajima, T. Gotanda, H. Uchimiya, T. Furukawa, M. Haraguchi, R. Ikeda, T. Sumizawa, H. Yoshida, and S.-i. Akiyama Inhibition of Metastasis of Tumor Cells Overexpressing Thymidine Phosphorylase by 2-Deoxy-L-Ribose Cancer Res., March 1, 2004; 64(5): 1794 - 1801. [Abstract] [Full Text] [PDF]

				N. Frickhofen, F.-J. Beck, B. Jung, H.-G. Fuhr, H. Andrasch, and M. Sigmund Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil Ann. Onc., May 1, 2002; 13(5): 797 - 801. [Abstract] [Full Text] [PDF]

				H. Uchimiya, T. Furukawa, M. Okamoto, Y. Nakajima, S. Matsushita, R. Ikeda, T. Gotanda, M. Haraguchi, T. Sumizawa, M. Ono, et al. Suppression of Thymidine Phosphorylase-mediated Angiogenesis and Tumor Growth by 2-Deoxy-L-ribose Cancer Res., May 1, 2002; 62(10): 2834 - 2839. [Abstract] [Full Text] [PDF]

				R. D. Leek, K. L. Talks, F. Pezzella, H. Turley, L. Campo, N. S. Brown, R. Bicknell, M. Taylor, K. C. Gatter, and A. L. Harris Relation of Hypoxia-inducible Factor-2{alpha} (HIF-2{alpha}) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer Cancer Res., March 1, 2002; 62(5): 1326 - 1329. [Abstract] [Full Text] [PDF]

				R. L. Schilsky, D. Bertucci, N. J. Vogelzang, H. L. Kindler, and M. J. Ratain Dose-Escalating Study of Capecitabine Plus Gemcitabine Combination Therapy in Patients With Advanced Cancer J. Clin. Oncol., January 15, 2002; 20(2): 582 - 587. [Abstract] [Full Text] [PDF]

				S.-i. Aishima, K.-i. Taguchi, K. Sugimachi, Y. Asayama, H. Nishi, M. Shimada, K. Sugimachi, and M. Tsuneyoshi The Role of Thymidine Phosphorylase and Thrombospondin-1 in Angiogenesis and Progression of Intrahepatic Cholangiocarcinoma International Journal of Surgical Pathology, January 1, 2002; 10(1): 47 - 56. [Abstract] [PDF]

				Y. Yao, T. Kubota, K. Sato, and R. Kitai Macrophage Infiltration-associated Thymidine Phosphorylase Expression Correlates with Increased Microvessel Density and Poor Prognosis in Astrocytic Tumors Clin. Cancer Res., December 1, 2001; 7(12): 4021 - 4026. [Abstract] [Full Text] [PDF]

				A. Giatromanolaki, M. I. Koukourakis, E. Sivridis, J. Pastorek, C. C. Wykoff, K. C. Gatter, and A. L. Harris Expression of Hypoxia-inducible Carbonic Anhydrase-9 Relates to Angiogenic Pathways and Independently to Poor Outcome in Non-Small Cell Lung Cancer Cancer Res., November 1, 2001; 61(21): 7992 - 7998. [Abstract] [Full Text] [PDF]

				H. Goto, K. Kohno, S. Sone, S.-i. Akiyama, M. Kuwano, and M. Ono Interferon {{gamma}}-dependent Induction of Thymidine Phosphorylase/Platelet-derived Endothelial Growth Factor through {{gamma}}-Activated Sequence-like Element in Human Macrophages Cancer Res., January 1, 2001; 61(2): 469 - 473. [Abstract] [Full Text]

				S. Takao, S.-i. Akiyama, A. Nakajo, H. Yoh, M. Kitazono, S. Natsugoe, K. Miyadera, M. Fukushima, Y. Yamada, and T. Aikou Suppression of Metastasis by Thymidine Phosphorylase Inhibitor Cancer Res., October 1, 2000; 60(19): 5345 - 5348. [Abstract] [Full Text]

				L. M. Strawn, F. Kabbinavar, D. P. Schwartz, E. Mann, L. K. Shawver, D. J. Slamon, and J. M. Cherrington Effects of SU101 in Combination with Cytotoxic Agents on the Growth of Subcutaneous Tumor Xenografts Clin. Cancer Res., July 1, 2000; 6(7): 2931 - 2940. [Abstract] [Full Text]